Management of Hepatocellular Carcinoma in Japan: Consensus-Based Clinical Practice Guidelines Proposed by the Japan Society of Hepatology (JSH) 2010 Updated Version
Management of Hepatocellular Carcinoma in Japan: Consensus-Based Clinical Practice Guidelines Proposed by the Japan Society of Hepatology (JSH) 2010 Updated Version
复制标题
DOI：
10.1159/000327577
复制
发表时间：
2011-01-01
影响因子：
2.3
通讯作者：
Makuuchi, Masatoshi
中科院分区：
文献类型：
--
作者：
Kudo, Masatoshi;Izumi, Namiki;Makuuchi, Masatoshi
肝细胞癌（HCC）不仅在日本而且在全世界都是癌症死亡的主要原因之一。 HCC 临床实践指南最初由欧洲肝脏研究学会 (EASL) 于 2001 年发布，随后美国肝病研究协会 (AASLD) 于 2005 年发布并于 2010 年更新。然而，这些指南已被证明有些不适合日本患者。 2005年，在日本厚生劳动省的支持下，日本编制了HCC循证临床实践指南。 2009年，公布了循证指南的修订版。基于“循证”指南和 HCC 专家组共识，日本肝病学会 (JSH) 于 2007 年出版了《基于共识的临床实践手册》，并于 2010 年进行了更新。本文总结了该手册 2010 年更新版本，特别是有关预防、监测、病理、诊断、分期和治疗算法的问题。版权所有 (C) 2011 S. Karger AG，巴塞尔
Hepatocellular carcinoma (HCC) is one of the leading causes of cancer death not only in Japan but also worldwide. Clinical practice guidelines for HCC were first published in 2001 by the European Society of Study of the Liver (EASL) followed by the American Association for the Study of Liver Disease (AASLD) published in 2005 and updated in 2010. However, these guidelines have proven to be somewhat unsuitable for Japanese patients. In 2005, supported by the Japanese Ministry of Health, Labour and Welfare, evidence-based clinical practice guidelines for HCC were compiled in Japan. In 2009, a revised version of evidence-based guidelines was published. Based on both 'evidence-based' guidelines and the consensus of an expert panel on HCC, the Japan Society of Hepatology (JSH) published the Consensus-Based Clinical Practice Manual in 2007 and updated in 2010. In this article, the 2010 updated version of this manual, especially issues on prevention, surveillance, pathology, diagnosis, staging, and treatment algorithm are summarized. Copyright (C) 2011 S. Karger AG, Basel